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Background: Congenital anomalies or birth defects are among the leading causes of infant mortality and
morbidity around the world. The impact of congenital anomalies is particularly severe in middle- and low-income
countries where health care resources are limited. The prevalence of congenital anomalies varies in different parts
of the world, which could reflect different aetiological factors in different geographical regions.
Methods: Between October 2012 and January 2013, a cross-sectional study was conducted involving young infants
below 2 months of age, admitted at a university teaching hospital in Tanzania. Face-to-face interviews with parents/
caretakers of young infants were carried out to collect socio-demographic and clinical information. Physical
examinations were performed on all young infants. Echocardiography, X-ray, cranial as well as abdominal
ultrasonographies were performed when indicated.
Results: Analysis of the data showed that among 445 young infants enrolled in the study, the prevalence of
congenital anomalies was 29%, with the Central Nervous System (CNS) as the most commonly affected organ system.
Maternal factors that were significantly associated with congenital anomalies included the lack of peri-conceptional use
of folic acid (OR = 3.1; 95% CI = 1.4-6.7; p = 0.005), a maternal age of above 35 years (OR = 2.2; 95% CI = 1.1-4.3;
p = 0.024) and an inadequate attendance to antenatal clinic (OR = 2.1; 95% CI = 1.4-3.3; p < 0.001). Infant factors that
were significantly associated with congenital anomalies were female sex, a birth weight of 2.5 kg or more, singleton
pregnancy and a birth order above 4.
Conclusions: Due to the high prevalence of congenital anomalies observed in this particular context, the hospital
should mobilize additional resources for an optimal and timely management of the patients with congenital anomalies.
In this study, the proportion of women taking folic acid supplements during early pregnancy was very low. Efforts
should be made to ensure that more women use folic acid during the peri-conceptional period, as the use of folic acid
supplement has been linked by several authors to a reduced occurrence of some congenital anomalies.Background
Congenital anomalies or birth defects are structural
or functional anomalies, including metabolic disorders,
which are present at the time of birth. Some of the
congenital anomalies may be life threatening, may impair
function or interfere with the cosmetic value of an individ-
ual, hence an immediate management is required. The
long-term disability caused by congenital anomalies may
have a significant impact not only on a child’s well being* Correspondence: manyama73@yahoo.com
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unless otherwise stated.and development, but also on families, health care systems
and societies [1]. The impact of congenital anomalies is se-
vere in middle- and low-income countries. As a matter of
fact, it is estimated that approximately 95% of the children
who die from birth defects are from those countries [1].
Worldwide, the incidence of congenital anomalies varies
between geographical regions but it is estimated that 3-7%
of children are born with birth defects [1-3]. Approxi-
mately, 270,000 newborns die during the first 28 days of
life every year from congenital anomalies [4]. In the
United States of America, congenital anomalies reportedly
affect 2-5% of all live births [3]. The magnitude of
congenital anomalies in Asia has been shown to vary withal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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[5,6]. In the Middle East, where consanguineous marriages
are common, the prevalence of major congenital anomalies
is reported to be 2–2.5%, the highest prevalence (7%) being
found in consanguineous marriages [1,5,7]. In Africa, some
of the rare studies on congenital anomalies have reported
an incidence between 1.5% and 2.5% in Egypt and East
Africa (Kenya and Uganda) respectively [8-10]. Reports on
the incidence of congenital anomalies in the developing
world should be taken with caution, as the absence of birth
defect registries in most of these countries, the deficiency
in diagnostic capabilities and unreliable medical records
and health statistics might increase the chances of under-
estimation. Most of the studies done in Africa have been
retrospective hospital-based studies which are usually af-
fected by underreporting and other sources of ascertain-
ment bias [11].
About 60% of the causes of congenital anomalies in
humans is still unknown [12]. However, in about 25% of
congenital anomalies, the causes seem to be “multifactorial”,
indicating a complex interaction between genetic and envir-
onmental risk factors [12]. A wide range of environmental
risk factors have been associated with the occurrence of
congenital anomalies [12]. Exposure during pregnancy to
drugs such as thalidomide and phenytoin, alcohol, cigarette
smoking, certain environmental chemicals and high doses
of radiation have all been implicated in the causation of con-
genital anomalies [13-15]. The occurrence of congenital
anomalies has also been associated with advanced maternal
and paternal age, parental consanguinity, increasing birth
order and low birth weight [14,16].
The pattern of congenital anomalies varies from region
to region and also over time [2]. Generally, congenital
anomalies that involve the CNSand the cardiovascular and
musculoskeletal systems have been reported to be the
most common [4,12,17].
Epidemiological surveys of congenital anomalies in vari-
ous parts of the world with different environment, socio-
economic status are likely to give out vital information on
the prevalence, pattern and risk factors for congenital
anomalies in different areas [18]. The current study was
conducted in order to determine the prevalence, pattern
and factors associated with congenital anomalies among
young infants admitted at a university hospital (Bugando
Medical Centre), Mwanza, Tanzania. Tanzania is a low-
resource African country where the magnitude of con-
genital anomalies and the associated factors are not well
documented. Results from this study will support the
development of strategies for improving the management
and rehabilitation of patients with congenital anomalies in
this particular context. Information on associated factors
may shed light on their roles as risk factors for the occur-
rence of congenital anomalies hence providing baseline
data for future studies and public health measures.Methods
Study setting and patients recruitment
This was a cross-sectional hospital-based study involv-
ing young infants below 2 months of age admitted at
the Bugando Medical Centre between October 2012 and
January 2013. The Bugando Medical Centre is a 1000-bed
capacity referral hospital in Tanzania serving about 15
million people. The hospital handles most of the congenital
anomaly cases of the regions around Lake Victoria because
of its capacity to offer specialized management. We en-
rolled young infants admitted at neonatal wards, pediatrics
surgical ward, general pediatrics wards and pediatrics
semi-intensive/critical care units. The ethical approval was
obtained from the joint Catholic University of Health and
Allied Sciences (CUHAS)/BMC ethical review board. The
sample size was calculated using the Yamane Taro formula
[19], whereby a total of 445 young infants with and without
congenital anomalies were recruited in the study. Patients
were recruited serially until the desired sample size was
reached. After a written consent was obtained from the
parents/caretakers, face-to-face interviews with parents/
caretakers of young infants were carried out to collect
socio-demographic and clinical information, such as ma-
ternal age and parity, history of Diabetes Mellitus, drug in-
take, exposure to X-ray, history of congenital malformation
in the family, parental consanguinity, residential area, ma-
ternal exposure to pollutants and number of antenatal
clinic visits. The birth weight of young infants was ob-
tained by asking the mother/caretaker and then confirmed
by observation of the antenatal card, infants Reproductive
and Child Health number one (RCH1) card or other
hospital documents, e.g. patient files.
Physical examination and imaging investigations
All young infants had a thorough physical examination
(general and systemic) performed by the paediatrician.
Echocardiography, X-ray imaging, cranial and abdominal
ultrasonography were performed when required. X-ray
films were interpreted by two independent radiologists.
Ultrasonography was performed by the radiologists and
the senior sonographer. Echocardiography was executed
by a paediatrician experienced in paediatric echocardiog-
raphy. Due to lack of relevant equipment and qualified
staff, genetic screening could not be performed.
The patterns of congenital anomalies were classified
according to the International Statistical Classification of
Diseases and Related Health Problems 10th Revision
(ICD-10) Version for congenital malformations, deforma-
tions and chromosomal abnormalities [20]. Young infants
with multiple congenital anomalies were grouped depend-
ing on whether those anomalies qualified as a specific
syndrome or not. If they qualified as a specific syndrome,
they were then categorized into that syndrome. If no
syndrome could be classified by those anomalies and two
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more than two systems were involved, it was recorded as
multiple congenital anomalies.
Data management and statistical analysis
Data were managed using EpiData version 3.1 (Atlanta, US)
and analysis was done using STATA version 11 (College
Station, Texas). Categorical variables were summarized as
proportions and were compared using Pearson’s Chi square
test while continuous data was described as medians (inter-
quartile range). Univariate followed by multivariate logistic
regression analyses were applied to determine the factors
associated with congenital anomalies. Factors with a p < 0.1
on univariate analysis were subjected to multivariate logistic
regression analysis. Crude (unadjusted) and adjusted odds
ratios were calculated to quantify the strength of associ-
ation between the factors and congenital anomalies. The
95% confidence intervals were determined and the factors
with a p-value of less than 0.05 were considered to have a
significant association with congenital anomalies.
Results
Among the 445 young infants admitted at BMC, 243
(54.6%) were males, 200 (44.9%) were females and 2
(0.5%) had ambiguous genitalia. The age range was
between one day and 60 days, with a median age of 4 with
an inter-quartile range of 2–8 days. Singleton and twins
accounted for 396 (89%) and 49 (11%) respectively, while a
birth order of equal or less than four accounted for 367
(83%). A family history of congenital anomalies was found
among 75 (3%) infants of the study sample.
Parental demographics showed that 339 (76.7%) of the
mothers of young infants were aged between 20 and
35 years of age and only 67 (15%) had used folic acid sup-
plements during the first trimester of last pregnancy. Fifty
mothers (11%) were exposed to passive smoking, 12 (3%)
used alcohol during pregnancy and none had a history of
active smoking or exposure to X-ray irradiation during
pregnancy. There was no history of consanguinity and
only one mother was using antiretroviral drugs during her
pregnancy.
During the study period, 131 infants among the 445 ex-
amined were found with congenital anomalies. This gives
a prevalence rate of 29%. The most affected body system
was the central nervous system which accounted for 39 of
the cases (29.8%), followed by the musculoskeletal and
gastrointestinal systems for 30 (22.9%) and 12 (9.2%) cases
respectively (Figure 1). Among the infants with CNS mal-
formations, spina bifida was the most common, followed
closely by hydrocephalus, with 16 (38.5%) and 14 (35.9%)
cases respectively (Table 1). Other CNS congenital anom-
alies are shown in Table 1.
Omphalocele was found to be the commonest congenital
anomaly affecting the musculoskeletal system, accountingfor 8 (26.8%) of all cases with musculoskeletal anomal-
ies, followed by gastroschisis 6 (20.0%) and polydactyl 5
(16.7%) [Table 2]. The most common anomaly of the
gastrointestinal tract (GIT) was imperforate anus, ac-
counting for 7 (58%) of all GIT malformations (Table 2).
Other malformations of the musculoskeletal and GIT
are shown in Table 2.
Maternal factors that were associated with congenital
anomalies were: Non use of folic acid during pregnancy
(OR = 3.1; 95% CI = 1.4-6.7; p = 0.005), a maternal age
above 35 years (OR = 2.2; 95% CI = 1.1-4.3; p = 0.024), and
three or less antenatal clinic (ANC) visits (OR = 2.1; 95%
CI = 1.4-3.3; p < 0.001) [Table 3]. Infant factors that were
significantly associated with congenital anomalies were:
Female sex (OR = 1.8; 95% CI = 1.1-2.8; p = 0.013), a birth
weight of 2.5 kg or more (OR = 2.3; 95% CI = 1.4-3.9; p =
0.002), singleton pregnancy (OR = 3.5; 95% CI = 1.2-10.9;
p = 0.027) and a birth order of 4 and above (OR = 4.4; 95%
CI = 2.6-7.6; p < 0.001) [Table 4].Discussion
Congenital anomalies are among the major causes of
childhood morbidity and mortality in many countries
around the world. The objective of this cross-sectional
study was to report on the prevalence, pattern as well as
factors associated with congenital anomalies among
young infants admitted at the Bugando Medical Centre in
Mwanza, Tanzania. Due to our study design, it was not
possible to determine a causal association of these factors
with congenital anomalies. In addition, the limited investi-
gative ability at BMC, made it impossible to perform gen-
etic/chromosomal or metabolic disorders studies.
About 29% of all young infants admitted at BMC during
the study period were found to have various congenital
anomalies. This prevalence is high compared the data pre-
viously reported in developing countries [8-10,21,22]. The
high prevalence of congenital anomalies in the present
study may be explained by the methodology employed by
looking for congenital anomalies among young infants ad-
mitted to a tertiary referral hospital. Most young infants
with congenital anomalies from regions surrounding Lake
Victoria are referred to Bugando Medical Centre, as this is
the only referral and consultant hospital capable of per-
forming specialized investigation as well as pediatric surgi-
cal care. In addition, the high prevalence observed in this
study could also be attributed to the type of classification
used in this study (ICD10) which does not differentiate
minor and major anomalies. A high prevalence of con-
genital anomalies of about 13% has also been reported
among neonates admitted in neonatal intensive care units
in low income countries [1]. Studies carried out among
deliveries in tertiary hospitals have reported lower preva-












































Malformation based on ICD10
Figure 1 Distribution of congenital anomalies according to ICD 10 among young infants admitted at Bugando Medical Centre from
October 2012 to Jan 2013. Key: CNS: central nervous system, MSS: musculoskeletal system, GIT: gastrointestinal tract, MCA: multiple
congenital anomalies involving at least 3 systems, CVS: cardiovascular system, US: urinary system, GS: genital system. Others: CNS + GIT,
CVS + GIT, GIT + GS, GIT + MSS, MSS + CVS, Pierre Robbin’s syndrome, Skin, Skin + MSS.
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the CNS were the most common. This could be due to
the fact that the surgical management of these malfor-
mations needs qualified personnel and special devices,
such as ventricular-peritoneal shunt tubes, only available
at BMC. Similar studies in Africa have reported a similar
trend [23,24]. Periconceptual multiple vitamin supple-
ments containing folic acid have been reported to reduce
the incidence of neural tube defects and orofacial clefts
[25-28]. Our results show that only 15% of the mothers
of young infants had used folic acid during the first tri-
mester of pregnancy and that non use folic acid was sig-
nificantly associated with congenital anomalies. Due to
the study design, the results however, were likely affected
by many factors, including recall bias.. Our findings are
similar to what was reported in Kenya and India whereTable 1 Specific CNS congenital anomalies among young
infants with CNS anomalies
CNS anomalies Number (%)
Spina bifida 16 (41.1)
Spina bifida and hydrocephalus 1 (2.6)
Abnormal brain tissue 1 (2.6)
Encephalocele and microcephaly 5 (12.8)
Hydrocephalus 14 (35.9)
Hydrocephalus with Dandy Walker cyst 1 (2.6)
Meningoencephalocele 1 (2.6)
Total 39 (100)CNS, musculoskeletal system and gastrointestinal tract
were the most affected systems [5,8]. Similar studies
elsewhere have reported that the musculoskeletal and
gastrointestinal systems are the body systems most com-
monly affected [9,18]. Differences in the pattern of body
systems affected by congenital anomalies among differ-
ent populations could reflect aetiological factors, such as
genetic and environmental factors [2].
A significant association between congenital anomalies
and the lack or peri-conceptional use of folic acid was
found in this study. Folic acid is known to be necessary for
the growth and smooth function of human cells, as it is
crucial for the biosynthesis and methylation of deoxyribo-
nucleic acid (DNA) and ribonucleic acid (RNA) [25]. This
is important for cell division, differentiation and regulation
of gene expression, especially at a time of rapid cell divisionTable 2 Musculoskeletal and gastrointestinal tract
anomalies among young infants






Imperforate anus 7 (58.3)
Oesophageal atresia 2 (16.7)
Ankyloglossia (tongue tie) 2 (16.7)
Cleft lip and palate 1 (8.3)
Table 3 Univariate and multivariate analysis for parental factors associated with congenital anomalies among young
infants admitted at Bugando Medical Centre
Parental risk factor Congenital malformations Unadjusted Adjusted
Yes No OR [95% CI] P-value OR [95% CI] P-value
Maternal age
≤35 112 (27.6) 293 (72.4) 1 1
>35 19 (47.5) 21 (52.5) 2.4 [1.2-4.6] 0.010 2.2 [1.1-4.3] 0.024
Antenatal visit
>3 visit 51 (21.3) 188 (78.7) 1 1
≤3 visit 79 (38.9) 124 (61.1) 2.3 [1.5-3.6] <0.001 2.1 [1.4-3.3] <0.001
Passive smoking
No 115 (29.3) 277 (70.7) 1
Yes 15 (30) 35 (70) 1.03 [0.5-2] 0.923 _ _
Maternal alcohol intake
No 129 (30) 301 (70) 1
Yes 1 (8.3) 11 (91.7) 0.21 [0.3-1.7] 0.140 _ _
Maternal use of folic acid
Yes 8 (11.9) 59 (88.11) 1 1
No 122 (32.5) 253 (67.5) 3.6 [1.6-7.7] 0.001 3.1 [1.4-6.7] 0.005
Paternal age
<45 117 (28.5) 293 (71.5) 1
≥45 13 (40.6) 19 (59.4) 1.7 [0.8-3.6] 0.152 _ _
Table 4 Univariate and multivariate analysis for infant factors associated with congenital anomalies among young
infants admitted at Bugando Medical Centre
Risk factors Congenital malformations Unadjusted Adjusted
Yes n (%) No n (%) OR [95% CI] P-value OR [95% CI] P-value
Sex
Male 64 (26.3) 179 (73.7) 1 1
Female 65 (32.5) 135 (67.5) 1.3 [0.9-2.0] 0.156 1.8 [1.1-2.8] 0.013
Birth order
≤4 87 (23.7) 280 (76.3) 1 1
>4 43 (57.3) 32 (42.7) 4.3 [2.6-7.3] <0.001 4.4 [2.6-7.6] <0.001
Pregnancy type
Twin 4 (8.2) 45 (91.8) 1 1
Singleton 127 (32.1) 269 (67.9) 5.3 [1.9-15.1] 0.002 3.5 [1.2-10.9] 0.027
History of birth defect
No 125 (29.1) 304 (70.9) 1
Yes 5 (38.5) 8 (61.5) 1.5 [0.5-4.7] 0.470 - -
Birth weight
<2.5 kg 26 (16.1) 135 (83.9) 1 1
≥2.5 kg 105 (37.0) 179 (63.0) 3.0 [1.9-4.9] <0.001 2.3 [1.4-3.9] 0.002
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a normal brain and spinal cord development during the
first 4 weeks of gestation [2]. Several studies have shown
that folic acid reduces the occurrence of some congenital
anomalies e.g. neural tube defects, oro-facial clefts, limb
reduction defects, congenital heart defects, urinary system
defects and omphalocele [26,27]. The low usage of folic
acid during the first trimester of pregnancy in this study
could explain the higher proportion of neural tube defects
and omphaloceles observed. The association between a low
usage of folic acid during pregnancy and the occurrence of
congenital anomalies has also been reported elsewhere [28].
The factors found to be significantly associated with
congenital anomalies included an inadequate attendance
to antenatal clinic, a maternal age above 35 years and a
birth order of above 4 children. Antenatal clinic visits are
an important part of prenatal care. During those visits,
health education is usually given on various issues includ-
ing adequate nutrition, avoidance of teratogens and mater-
nal infections. Multiple vitamin supplements containing
folic acid are also distributed during the clinic sessions
[29]. The antenatal visits therefore aim at ensuring a nor-
mal pregnancy with the delivery of a healthy baby from a
healthy mother. Few (≤3) or no prenatal clinic visits have
previously been associated with the occurrence of con-
genital anomalies [30].
Gametogenesis in females begins before birth and the
first meiotic division is usually completed shortly before
ovulation. Sometimes, the first meiotic division may take a
long time to be completed, e.g. up to 45 years. In such cir-
cumstances, the chances for meiotic errors from exposure
to teratogens are very high because the oocyte spends a
longer time in a dividing stage (prophase stage). The risk
for congenital anomalies from chromosomal abnormalities
as maternal age increases (especially above 35 years) is ex-
pected to be high [8,10,12]. An association between a high
birth order and the occurrence of congenital anomalies
was previously reported [2,21]. This link was attributed to
the increased rate of mutation after the 3rd gravid com-
pared to the first and second gravid, as well as a higher
maternal age [2,31].
A singleton pregnancy, a birth weight of 2.5 kg and above,
a birth order of 4 and above and female sex were also found
to be associated with congenital anomalies. We were unable
to explain these findings due to the design of our study.
Our findings indicate that maternal smoking (passive
smoking), alcohol consumption and a family history of
congenital anomalies were not associated with congenital
anomalies. Maternal cigarette smoking and alcohol con-
sumption have previously been reported as risk factors for
the occurrence of congenital anomalies including orofacial
clefts and congenital heart diseases [15,32-34]. Cigarette
smoking and alcohol intake are not common among
Tanzanian women due to cultural norms. In addition,under ascertainment bias could have also affected our
results due to non-reporting of family history because of
shame, etc. A family history of birth defects has been asso-
ciated with an increased risk of having another children
with congenital anomalies, with a recurrence rate ranging
between 2 and 5% and 1% for neural tube defects and
Down syndrome respectively [35].
The significance of the association between congenital
anomalies and various factors in this study should be
interpreted with care. As a matter of fact, the information
on associated factors was obtained through interviews and
is likely to be affected by recall bias of former exposure to
risk variables as well as denial from parents regarding the
exposure to some of the factors due to fact occurrence of
congenital anomalies is a delicate issue to most families.
In addition, our results of associated factors are also likely
to be influenced by under-ascertainment and use of BMC
as the only data source.
Conclusion
The high prevalence of congenital anomalies observed in
this study calls for a special attention on this problem. We
recommend that the hospital should mobilize more re-
sources for an optimal and timely management of patients
with congenital anomalies. Large community-based stud-
ies should be conducted in Tanzania to determine the
prevalence of congenital anomalies among the newborns
and their associated factors. The results could shed light
on the pattern as well as the various risk factors for
congenital anomalies.
In this study, the proportion of women taking folic acid
supplements during early pregnancy was very low. Even
though, due to its design, our study could not establish a
causal relationship between non-use of folic acid and the
occurrence of congenital anomalies, efforts should be
made to ensure that more women use folic acid during
the periconceptional period since there is ample docu-
mentation about its association with congenital anomalies
Similarly, pregnancies and deliveries at an advanced age
should be discouraged as they have been associated in
various studies with the occurrence of congenital anomal-
ies. Large community-based studies in different geograph-
ical, environmental and socio-economic settings should be
conducted in Tanzania to determine the prevalence of
congenital anomalies and their associated factors.
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